Mair Grant, Boyd Elena V, Chappell Francesca M, von Kummer Rüdiger, Lindley Richard I, Sandercock Peter, Wardlaw Joanna M
From the Division of Neuroimaging Sciences, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom (G.M., F.M.C., P.S., J.M.W.); Department of Radiology, Northwick Park Hospital, Harrow, United Kingdom (E.V.B.); Department of Neuroradiology, Dresden University Stroke Centre, University Hospital, Dresden, Germany (R.v.K.); and Westmead Hospital Clinical School and The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia (R.I.L.).
Stroke. 2015 Jan;46(1):102-7. doi: 10.1161/STROKEAHA.114.007036. Epub 2014 Dec 4.
In acute ischemic stroke, the hyperdense artery sign (HAS) on noncontrast computed tomography (CT) is thought to represent intraluminal thrombus and, therefore, is a surrogate of arterial obstruction. We sought to assess the accuracy of HAS as a marker of arterial obstruction by thrombus.
The Third International Stroke Trial (IST-3) was a randomized controlled trial testing the use of intravenous thrombolysis for acute ischemic stroke in patients who did not clearly meet the prevailing license criteria. Some participating IST-3 centers routinely performed CT or MR angiography at baseline. One reader assessed all relevant scans independently, blinded to all other data; we checked observer reliability. We combined IST-3 data with a systematic review and meta-analysis of all studies that assessed the accuracy of HAS using angiography (any modality).
IST-3 had 273 patients with baseline CT or MR angiography and was the largest study of HAS accuracy. The meta-analysis (n=902+273=1175, including IST-3) found sensitivity and specificity of HAS for arterial obstruction on angiography to be 52% and 95%, respectively. HAS was more commonly identified in proximal than distal arteries (47% versus 37%; P=0.015), and its sensitivity increased with thinner CT slices (r=-0.73; P=0.001). Neither extent of obstruction nor time after stroke influenced HAS accuracy.
When present in acute ischemic stroke, HAS indicates a high likelihood of arterial obstruction, but its absence indicates only a 50/50 chance of normal arterial patency. Thin-slice CT improves sensitivity of HAS detection.
http://www.controlled-trials.com/ISRCTN25765518. Unique identifier: ISRCTN25765518.
在急性缺血性卒中中,非增强计算机断层扫描(CT)上的高密度动脉征(HAS)被认为代表管腔内血栓,因此是动脉阻塞的替代指标。我们旨在评估HAS作为血栓性动脉阻塞标志物的准确性。
第三次国际卒中试验(IST-3)是一项随机对照试验,测试在未明确符合现行许可标准的急性缺血性卒中患者中使用静脉溶栓治疗。一些参与IST-3的中心在基线时常规进行CT或磁共振血管造影。一名阅片者对所有相关扫描进行独立评估,对所有其他数据保持盲态;我们检查了观察者的可靠性。我们将IST-3数据与对所有使用血管造影(任何方式)评估HAS准确性的研究进行的系统评价和荟萃分析相结合。
IST-3有273例患者进行了基线CT或磁共振血管造影,是关于HAS准确性的最大规模研究。荟萃分析(n = 902 + 273 = 1175,包括IST-3)发现,HAS对血管造影显示的动脉阻塞的敏感性和特异性分别为52%和95%。HAS在近端动脉中比在远端动脉中更常见(47%对37%;P = 0.015),其敏感性随CT层厚变薄而增加(r = -0.73;P = 0.001)。阻塞程度和卒中后时间均不影响HAS的准确性。
在急性缺血性卒中中出现HAS时,提示动脉阻塞的可能性很高,但未出现HAS仅表明动脉通畅的可能性为50/50。薄层CT可提高HAS检测的敏感性。
http://www.controlled-trials.com/ISRCTN25765518。唯一标识符:ISRCTN25765518。